Eisai
4523.T
#2173
Rank
C$11.78 B
Marketcap
C$41.78
Share price
0.75%
Change (1 day)
0.78%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.20. an increase over its 2024 EPS that were of C$1.35.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025C$1.5111.85%
2024C$1.35-32.63%
2023C$2.015.52%
2022C$1.90-74.01%
2021C$7.32-66.58%
2020C$21.9198.24%
2019C$11.0517.01%
2018C$9.4537.78%
2017C$6.86-27.62%
2016C$9.4735.33%
2015C$7.00-2.82%
2014C$7.20-27.66%
2013C$9.96-27.49%
2012C$13.73-12.67%
2011C$15.7288.08%
2010C$8.36-11.06%
2009C$9.40-390.15%
2008C-$3.24-127.78%
2007C$11.6611.78%
2006C$10.444.38%
2005C$10.007.4%
2004C$9.3143.03%
2003C$6.5125.09%
2002C$5.2052.67%
2001C$3.4169.76%
2000C$2.01